21 Jan 2016 10:14
21 January 2016
Collagen Solutions Plc
(the "Company" or the "Group")
Chairman's Share Purchase
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that David Evans, Chairman of the Company, has today purchased 1,000,000 ordinary shares in the Company at 7.5 pence per share.
Following this transaction, David Evans total beneficial holding has increased to 13,888,730 ordinary shares representing 8.1 per cent of the issued ordinary share capital of the Company.
David Evans, Non-Executive Chairman, commented: "As was announced in the recent trading update, I have purchased a further one million shares in Collagen Solutions which re-affirms my commitment to the Company and strong belief in the growth potential that the Company offers."
Enquiries:
Collagen Solutions Plc | ||
David Evans, Chairman | Tel: 07740 084 452 | |
Stewart White, CEO | Tel: 07795 504 465 | |
Panmure Gordon & Co | ||
Robert Naylor (Corporate Finance) Maisie Atkinson (Corporate Broking) | Tel: 020 7886 2714Tel: 020 7886 2905 | |
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com | |
Mike Wort | Mob: 07900 608 002 | |
Anna Dunphy | Mob: 07876 741 001 | |